Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.
Also called NCT03318276
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 170 participants
- Sponsor
- Registry
-
NCT03318276
-
- Other papers using this trial's data
- Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03318276. Randomized; triple masking; primary purpose treatment. Start 2017-02-20 (actual); primary completion 2018-10-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease
- Condition
- Peripheral Arterial Disease
- Intervention (Drug)
- SID142
- Intervention (Drug)
- Rinexin® Tab
- Lead sponsor
- SK Chemicals Co., Ltd.
Record details
- Record id
cardio:ct-nct03318276- Content hash
42ca0c96e1df976f88ae5a424234c20998bcb4fb5630ca00c0027bca64e7bfc7